Human neutrophils in the saga of cellular heterogeneity: insights and open questions

Immunological Reviews

Volumn 273, Issue 1, 2016, Pages 48-60

  Scapini, Patrizia ^a   Marini, Olivia ^a   Tecchio, Cristina ^a   Cassatella, Marco A ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

G MDSCs; inflammation; LDGs; LDNs; neutrophils

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; CELL DENSITY; CELL HETEROGENEITY; CELL ISOLATION; CELL MATURATION; CELL STRUCTURE; CHRONIC GRANULOMATOUS DISEASE; GRANULOCYTE; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOPHENOTYPING; INFLAMMATION; LEUKOCYTE ACTIVATION; LOW DENSITY GRANULOCYTE; LOW DENSITY NEUTROPHIL; NEOPLASM; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84983493347     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12448     Document Type: Review

References (130)

1. Scapini P, Tamasia N, Pucillo C, Cassatella MA. Granulocytes and mast cells. In: Paul W, et al. eds. Fundamental Immunology. 7th edn. Philadelphia, PA: Wolters Kluwer-Lippincott Williams & Wilkins, 2013:468–486.
2. Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol 2014;15:602–611.
3. Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Annu Rev Pathol 2014;9:181–218.
4. Leliefeld PH, Koenderman L, Pillay J. How neutrophils shape adaptive immune responses. Front Immunol 2015;6:471.
5. Scapini P, Cassatella MA. Social networking of human neutrophils within the immune system. Blood 2014;124:710–719.
6. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, Mantovani A. Neutrophils in innate and adaptive immunity. Semin Immunopathol 2013;35:377–394.
7. Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med 2013;210:1283–1299.
8. Headland SE, Norling LV. The resolution of inflammation: principles and challenges. Semin Immunol 2015;27:149–160.
9. Beyrau M, Bodkin JV, Nourshargh S. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol 2012;2:120134.
10. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 2012;61:1155–1167.
11. Pillay J, Tak T, Kamp VM, Koenderman L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol Life Sci 2013;70:3813–3827.
12. Carmona-Rivera C, Kaplan MJ. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol 2013;35:455–463.
13. Silvestre-Roig C, Hidalgo A, Soehnlein O. Neutrophil heterogeneity: implications for homeostasis and pathogenesis. Blood 2016; Mar 21. pii: blood-2016-01-688887.
14. Gallin JI. Human neutrophil heterogeneity exists, but is it meaningful? Blood 1984;63:977–983.
15. Puellmann K, et al. A variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci USA 2006;103:14441–14446.
16. Fuchs T, et al. The neutrophil recombinatorial TCR-like immune receptor is expressed across the entire human life span but repertoire diversity declines in old age. Biochem Biophys Res Commun 2012;419:309–315.
17. Clemmensen SN, et al. Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 2012;91:495–500.
18. Welin A, et al. The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro. PLoS ONE 2013;8:e69575.
19. Amirbeagi F, et al. Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils. J Leukoc Biol 2015;97:181–189.
20. Bauer S, Abdgawad M, Gunnarsson L, Segelmark M, Tapper H, Hellmark T. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J Leukoc Biol 2007;81:458–464.
21. von Vietinghoff S, et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 2007;109:4487–4493.
22. Wang L, Ge S, Agustian A, Hiss M, Haller H, von Vietinghoff S. Surface receptor CD177/NB1 does not confer a recruitment advantage to neutrophilic granulocytes during human peritonitis. Eur J Haematol 2013;90:436–437.
23. + neutrophils increase in allergic asthmatic subjects. Allergy Asthma Clin Immunol 2013;9:23.
24. Hu N, et al. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS ONE 2014;9:e99671.
25. Kuckleburg CJ, Tilkens SB, Santoso S, Newman PJ. Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol 2012;188:2419–2426.
26. Massena S, et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 2015;126:2016–2026.
27. Sigua JA, et al. CD49d-expressing neutrophils differentiate atopic from nonatopic individuals. J Allergy Clin Immunol 2014;133:901–904 e905.
28. Pliyev BK, Shmidt EI, Ivanova AV, Menshikov M. Circulating CD35(-)/CD49d(+) neutrophils in influenza virus infection patients. Hum Immunol 2012;73:1087–1090.
29. Lohri C, et al. Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Res 2014;34:4693–4699.
30. Buckley CD, et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 2006;79:303–311.
31. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159–175.
32. Manz MG, Boettcher S. Emergency granulopoiesis. Nat Rev Immunol 2014;14:302–314.
33. Roxburgh CS, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 2014;110:1409–1412.
34. Munoz LE, et al. Autoimmunity and chronic inflammation – two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010;10:38–42.
35. Cloke T, Munder M, Taylor G, Muller I, Kropf P. Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS ONE 2012;7:e48939.
36. Rodriguez PC, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009;69:1553–1560.
37. Ssemaganda A, et al. Characterization of neutrophil subsets in healthy human pregnancies. PLoS ONE 2014;9:e85696.
38. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 2002;28:260–274.
39. + granulocytes which inhibit T cell function. J Immunol Methods 2009;341:68–75.
40. + T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136:35–45.
41. Jiang J, Guo W, Liang X. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients. Hum Immunol 2014;75:1128–1137.
42. Mundy-Bosse BL, et al. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4(+) T cells from patients with GI malignancy. Cancer Immunol Immunother 2011;60:1269–1279.
43. Li J, Srivastava RM, Ettyreddy A, Ferris RL. Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients. J Immunother Cancer 2015;3:54.
44. Hossain DM, et al. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clin Cancer Res 2015;21:3771–3782.
45. Giallongo C, et al. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients. PLoS ONE 2014;9:e101848.
46. Marini O, et al. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget 2016; Mar 30. doi: 10.18632/oncotarget.8507.
47. Mare TA, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care 2015;19:57.
48. Cloke T, et al. Phenotypic alteration of neutrophils in the blood of HIV seropositive patients. PLoS ONE 2013;8:e72034.
49. Deng Y, et al. Low-Density Granulocytes Are Elevated in Mycobacterial Infection and Associated with the Severity of Tuberculosis. PLoS ONE 2016;11:e0153567.
50. Grayson PC, et al. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 2015;67:1922–1932.
51. Midgley A, Beresford MW. Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. Lupus 2016;25:407–411.
52. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 2001;61:4756–4760.
53. Zea AH, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005;65:3044–3048.
54. Sippel TR, et al. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res 2011;17:6992–7002.
55. Brandau S, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011;89:311–317.
56. Ramachandran IR, et al. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. J Immunol 2013;190:3815–3823.
57. Gorgun GT, et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 2013;121:2975–2987.
58. Favaloro J, et al. Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. Leuk Lymphoma 2014;55:2893–2900.
59. Christiansson L, et al. The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses. Mol Cancer Ther 2015;14:1181–1191.
60. Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog 2014;10:e1003993.
61. Darcy CJ, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care 2014;18:R163.
62. Janols H, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol 2014;96:685–693.
63. Rieber N, et al. Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD. Bone Marrow Transplant 2014;49:545–552.
64. Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB. Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma 2010;68:843–852.
65. Kostlin N, et al. Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol 2014;44:2582–2591.
66. Gervassi A, et al. Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses. PLoS ONE 2014;9:e107816.
67. Rieber N, et al. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol 2013;174:45–52.
68. Luyckx A, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol 2012;143:83–87.
69. Vasconcelos ZF, et al. T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. Cytotherapy 2003;5:336–345.
70. Brandau S, Moses K, Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin Cancer Biol 2013;23:171–182.
71. Eruslanov E, et al. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer 2012;130:1109–1119.
72. Vollbrecht T, et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012;26:F31–F37.
73. Alfaro C, et al. Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs). Clin Cancer Res 2016;Mar 8. pii: clincanres.2463.2015.
74. Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci 2014;1319:47–65.
75. Mandruzzato S, et al. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. Cancer Immunol Immunother 2016;65:161–169.
76. Sagiv JY, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep 2015;10:562–573.
77. Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum 1986;29:1334–1342.
78. Denny MF, et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010;184:3284–3297.
79. Villanueva E, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011;187:538–552.
80. Lood C, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 2016;22:146–153.
81. Lin AM, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011;187:490–500.
82. Bennett L, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711–723.
83. Singh N, Traisak P, Martin KA, Kaplan MJ, Cohen PL, Denny MF. Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus. Arthritis Res Ther 2014;16:R165.
84. Garcia-Romo GS, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011;3:73ra20.
85. Van Avondt K, Fritsch-Stork R, Derksen RH, Meyaard L. Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus. PLoS ONE 2013;8:e78459.
86. Morisaki T, Goya T, Ishimitsu T, Torisu M. The increase of low density subpopulations and CD10 (CALLA) negative neutrophils in severely infected patients. Surg Today 1992;22:322–327.
87. van den Akker EL, et al. Ficoll-separated mononuclear cells from sepsis patients are contaminated with granulocytes. Intensive Care Med 2008;34:912–916.
88. Drifte G, Dunn-Siegrist I, Tissieres P, Pugin J. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit Care Med 2013;41:820–832.
89. Taneja R, Sharma AP, Hallett MB, Findlay GP, Morris MR. Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling. Shock 2008;30:618–622.
90. Trellakis S, et al. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int J Immunopathol Pharmacol 2011;24:683–693.
91. Demaret J, et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol 2015;98:1081–1090.
92. Pillay J, et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol 2010;88:211–220.
93. Pillay J, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012;122:327–336.
94. Guerin E, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*. Crit Care Med 2014;42:2007–2018.
95. Bae MH, et al. Flow cytometric measurement of respiratory burst activity and surface expression of neutrophils for septic patient prognosis. Cytometry B Clin Cytom 2015;Jul 22. doi: 10.1002/cyto.b.21274.
96. Fu J, Tobin MC, Thomas LL. Neutrophil-like low-density granulocytes are elevated in patients with moderate to severe persistent asthma. Ann Allergy Asthma Immunol 2014;113:635–640 e632.
97. Rocha BC, et al. Type I Interferon Transcriptional Signature in Neutrophils and Low-Density Granulocytes Are Associated with Tissue Damage in Malaria. Cell Rep 2015;13:2829–2841.
98. low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol 2012;33:121–129.
99. Tsuda Y, et al. An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. J Clin Biochem Nutr 2012;51:204–212.
100. de Kleijn S, et al. IFN-gamma-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLoS ONE 2013;8:e72249.
101. Hao S, Andersen M, Yu H. Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients. Am J Blood Res 2013;3:239–245.
102. Guan Q, et al. Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation. Biol Blood Marrow Transplant 2015;21:1205–1214.
103. dim immunosuppressive subset. J Gerontol A Biol Sci Med Sci 2016; pii: glw062.
104. Puga I, et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012;13:170–180.
105. Magri G, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol 2014;15:354–364.
106. Nagelkerke SQ, aan de Kerk DJ, Jansen MH, van den Berg TK, Kuijpers TW. Failure to detect functional neutrophil B helper cells in the human spleen. PLoS ONE 2014;9:e88377.
107. Kostlin N, et al. Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype. J Immunol 2016;196:1132–1145.
108. Amsalem H, et al. Identification of a novel neutrophil population: proangiogenic granulocytes in second-trimester human decidua. J Immunol 2014;193:3070–3079.
109. Croxatto D, et al. Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua. Mucosal Immunol 2016;Feb 24. doi: 10.1038/mi.2016.10.
110. Ingersoll SA, et al. Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1. J Immunol 2015;194:5520–5528.
111. Wu P, et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014;40:785–800.
112. Eruslanov EB, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014;124:5466–5480.
113. Mishalian I, Granot Z, Fridlender ZG. The diversity of circulating neutrophils in cancer. Immunobiology 2016;Feb 3. pii: S0171-2985(16)30017-1. doi: 10.1016/j.imbio.2016.02.001.
114. Uribe-Querol E, Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res 2015;2015:983698.
115. Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 2012;91:167–181.
116. Fridlender ZG, et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 2012;7:e31524.
117. Mishalian I, Bayuh R, Levy L, Zolotarov L, Michaeli J, Fridlender ZG. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother 2013;62:1745–1756.
118. Fridlender ZG, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 2009;16:183–194.
119. Liang W, Ferrara N. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunol Res 2016;4:83–91.
120. Powell DR, Huttenlocher A. Neutrophils in the Tumor Microenvironment. Trends Immunol 2016;37:41–52.
121. Granot Z, Jablonska J. Distinct Functions of Neutrophil in Cancer and Its Regulation. Mediators Inflamm 2015;2015:701067.
122. Davey MS, et al. Failure to detect production of IL-10 by activated human neutrophils. Nat Immunol 2011;12:1017–1018; author reply 1018–1020.
123. Pelletier M, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010;115:335–343.
124. Tamarozzi F, Wright HL, Thomas HB, Edwards SW, Taylor MJ. A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry. Immunol Lett 2014;162:194–198.
125. Taylor PR, Pearlman E. IL-17A production by neutrophils. Immunol Lett 2016;169:104–105.
126. Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells–fact or fancy? Trends Immunol 2006;27:282–290.
127. + T cells. J Leukoc Biol 2010;88:1163–1170.
128. Lindau D, et al. TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen. Ann Rheum Dis 2014;73:2199–2207.
129. Zimmermann M, et al. IFNalpha enhances the production of IL-6 by human neutrophils activated via TLR8. Sci Rep 2016;6:19674.
130. Ko JS, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 2009;15:2148–2157.